Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Debt / NOTE 5.250%12/0
-
Number of holders
-
12
-
Total 13F principal, excl. options
-
87,500,000
-
Principal change
-
+2,150,000
-
Total reported value, excl. options
-
$141,157,000
-
Value change
-
+$3,228,692
-
Number of buys
-
4
-
Number of sells
-
-3
-
Price
-
$1.61
Significant Holders of LEXICON PHARMACEUTICALS INC - NOTE 5.250%12/0 as of Q1 2016
13 filings reported holding 528872AB0 - LEXICON PHARMACEUTICALS INC - NOTE 5.250%12/0 as of Q1 2016.
LEXICON PHARMACEUTICALS INC - NOTE 5.250%12/0 has 12 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $87,500,000 of principal
.
Largest 10 bondholders include LINDEN ADVISORS LP ($20,125,000 of principal), UBS ASSET MANAGEMENT AMERICAS INC ($12,000,000 of principal), CITADEL ADVISORS LLC ($9,100,000 of principal), UBS OCONNOR LLC ($8,500,000 of principal), LAZARD ASSET MANAGEMENT LLC ($8,250,000 of principal), WOLVERINE ASSET MANAGEMENT LLC ($8,000,000 of principal), ANGELO GORDON & CO., L.P. ($8,000,000 of principal), Polygon Management Ltd. ($6,500,000 of principal), Clearbridge Investments, LLC ($3,000,000 of principal), and Verition Fund Management LLC ($2,000,000 of principal).
This table shows the top 12 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.